Metraipolis › archive › dc_fc06821834d2

Methylglyoxal as a Convergent Mediator of Diabetic Complications: Generation, Protein Targets, Tissue Distribution, and Therapeutic Reduction-A Clinically… — Europe PMC PMID:42650772

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42650772
DOI
10.3390/biom16081104
License (as archived)
solo-consultazione
Archived
2026-10-17T10:38:22.437Z
SHA-256 of the archived text
110e5d9299adc0ae2d7af6691cd373621a204a29275d7224ed68f970b94e09b0
Stable URL of this page
https://metraipolis.com/documento/dc_fc06821834d2

How to cite

Methylglyoxal as a Convergent Mediator of Diabetic Complications: Generation, Protein Targets, Tissue Distribution, and Therapeutic Reduction-A Clinically… — Europe PMC PMID:42650772 — Europe PMC (en), https://europepmc.org/article/MED/42650772 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc06821834d2 (Metraipolis archive dc_fc06821834d2, sha256 110e5d9299adc0ae2d7af6691cd373621a204a29275d7224ed68f970b94e09b0)
BibTeX
@misc{dcfc06821834d2,
  title = {Methylglyoxal as a Convergent Mediator of Diabetic Complications: Generation, Protein Targets, Tissue Distribution, and Therapeutic Reduction-A Clinically… — Europe PMC PMID:42650772},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42650772},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc06821834d2; sha256 110e5d9299adc0ae2d7af6691cd373621a204a29275d7224ed68f970b94e09b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42650772. Agents can read the archived copy with the MCP tool read_document.